DE69717109T2 - 1,4-disubstituierte piperdine als muskarin-antagonisten - Google Patents

1,4-disubstituierte piperdine als muskarin-antagonisten

Info

Publication number
DE69717109T2
DE69717109T2 DE69717109T DE69717109T DE69717109T2 DE 69717109 T2 DE69717109 T2 DE 69717109T2 DE 69717109 T DE69717109 T DE 69717109T DE 69717109 T DE69717109 T DE 69717109T DE 69717109 T2 DE69717109 T2 DE 69717109T2
Authority
DE
Germany
Prior art keywords
alkyl
cycloalkyl
heteroaryl
aryl
alkylheteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69717109T
Other languages
English (en)
Other versions
DE69717109D1 (de
Inventor
Theodros Asberom
B Lowe
J Green
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE69717109D1 publication Critical patent/DE69717109D1/de
Publication of DE69717109T2 publication Critical patent/DE69717109T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69717109T 1996-07-10 1997-07-08 1,4-disubstituierte piperdine als muskarin-antagonisten Expired - Fee Related DE69717109T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67861896A 1996-07-10 1996-07-10
PCT/US1997/011176 WO1998001425A1 (en) 1996-07-10 1997-07-08 1,4-di-sustituted piperidines as muscarinic antagonists

Publications (2)

Publication Number Publication Date
DE69717109D1 DE69717109D1 (de) 2002-12-19
DE69717109T2 true DE69717109T2 (de) 2003-04-30

Family

ID=24723553

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69717109T Expired - Fee Related DE69717109T2 (de) 1996-07-10 1997-07-08 1,4-disubstituierte piperdine als muskarin-antagonisten

Country Status (14)

Country Link
EP (1) EP0912515B1 (de)
JP (1) JP3068206B2 (de)
KR (1) KR20000023599A (de)
AT (1) ATE227708T1 (de)
AU (1) AU728592B2 (de)
CA (1) CA2259655C (de)
DE (1) DE69717109T2 (de)
DK (1) DK0912515T3 (de)
ES (1) ES2182104T3 (de)
HU (1) HUP9904622A3 (de)
IL (1) IL127942A0 (de)
NZ (1) NZ333513A (de)
PT (1) PT912515E (de)
WO (1) WO1998001425A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251919B1 (en) * 1998-02-27 2001-06-26 Warner-Lambert Heterocyclic substituted aniline calcium channel blockers
US6387930B1 (en) 1999-05-04 2002-05-14 Schering Corporation Piperidine derivatives useful as CCR5 antagonists
AU780983B2 (en) * 1999-05-04 2005-04-28 Schering Corporation Piperidine derivatives useful as CCR5 antagonists
US6635646B1 (en) 1999-05-04 2003-10-21 Schering Corporation Pegylated interferon alfa-CCR5 antagonist combination HIV therapy
AR033517A1 (es) 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
KR20030017502A (ko) 2000-04-28 2003-03-03 에프. 호프만-라 로슈 아게 파라(설포닐)아릴 및 헤테로아릴
US6640155B2 (en) 2000-08-22 2003-10-28 Lam Research Corporation Chemical mechanical polishing apparatus and methods with central control of polishing pressure applied by polishing head
ES2258642T3 (es) 2001-07-02 2006-09-01 Astrazeneca Ab Derivados de piperidina utiles como moduladores de la actividad del receptor de quimiocina.
GB0120461D0 (en) 2001-08-22 2001-10-17 Astrazeneca Ab Novel compounds
AR036366A1 (es) 2001-08-29 2004-09-01 Schering Corp Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
GB0122503D0 (en) 2001-09-18 2001-11-07 Astrazeneca Ab Chemical compounds
MXPA04005313A (es) 2001-12-03 2004-09-13 Hoffmann La Roche Derivados de aminotetralin como antagonistas del receptor muscarinico.
SE0200843D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200844D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
JP4675103B2 (ja) 2002-06-14 2011-04-20 富山化学工業株式会社 脳機能を改善する医薬組成物および脳機能を改善するための方法
SE0202838D0 (sv) * 2002-09-24 2002-09-24 Astrazeneca Ab Chemical compounds
GB0223223D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
SE0300957D0 (sv) 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
EP2402316A1 (de) 2005-07-21 2012-01-04 AstraZeneca AB (Publ) Piperidinderivate
US8153804B2 (en) 2005-08-02 2012-04-10 Lexicon Pharmaceuticals, Inc. Aryl pyridines and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100299734B1 (ko) * 1993-07-28 2002-01-09 모리타 다카카즈 1,4-(디페닐알킬)피페라진유도체
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists

Also Published As

Publication number Publication date
JP3068206B2 (ja) 2000-07-24
PT912515E (pt) 2003-03-31
HUP9904622A3 (en) 2001-07-30
CA2259655C (en) 2003-05-13
EP0912515A1 (de) 1999-05-06
KR20000023599A (ko) 2000-04-25
ATE227708T1 (de) 2002-11-15
JPH11514671A (ja) 1999-12-14
EP0912515B1 (de) 2002-11-13
AU728592B2 (en) 2001-01-11
DK0912515T3 (da) 2003-03-10
DE69717109D1 (de) 2002-12-19
HUP9904622A2 (hu) 2000-06-28
NZ333513A (en) 2000-04-28
CA2259655A1 (en) 1998-01-15
AU3581097A (en) 1998-02-02
IL127942A0 (en) 1999-11-30
WO1998001425A1 (en) 1998-01-15
ES2182104T3 (es) 2003-03-01

Similar Documents

Publication Publication Date Title
DE69717109T2 (de) 1,4-disubstituierte piperdine als muskarin-antagonisten
DE69733478D1 (de) Ether-muskarinantagonisten
MY133992A (en) Muscarinic antagonists
DK1240142T3 (da) Nye modulatorer af dopaminneurotransmission
ATE224884T1 (de) Muscarin-antagonisten
RU2005114489A (ru) N-акрил-4-метиленамино-3-гидрокси-2-пиридоны в качестве противомикробных препаратов
NO990551L (no) Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
EP1679069A4 (de) Neues piperidinderivat
SE9902648D0 (sv) Kondenserade pyrrolkarboxanilider
YU8703A (sh) Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1
ATE265432T1 (de) 3-amino-5-carboxy-substituierte piperidine und 3- amino-4-carboxy-substituierte pyrrolidine als tachykinin-antagonisten
PT863136E (pt) Derivados de azetidina e de pirrolidina
NZ307505A (en) Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
MY133108A (en) Muscarinic antagonists
DE69022744D1 (de) Piperidin und pyrrolidin derivate.
BR0208823A (pt) Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica
CO5180624A1 (es) Antagonistas muscarinicos
ATE420860T1 (de) N-substituierte amide als nk1 rezeptor antagonisten
DK1178047T3 (da) Diazabicyclooctanderivater og terapeutiske anvendelser deraf
RU2003105827A (ru) Средства против слабоумия, содержащие производные 2-арил-8-оксодигидропурина, в качестве активного ингредиента

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee